Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catch™ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs.

Education

Pharmaceutical

Polyneuron Pharmaceuticals

Ruben Herrendorff

Pascal Haenggi

Debra Barker

Juergen Jaeger

Nick Pearson

Polyneuron Pharmaceuticals' Founding Team includes Ruben Herrendorff.

Founding Team

Leadership Team

Board of Directors

CEO and Executive Team

Founding Team

About

Team members

Other teams at Polyneuron Pharmaceuticals

Leadership Team

Board of Directors

CEO and Executive Team